Foodborne antibiotics enrich human gut microbiota with pathogens producing extended-spectrum β-lactamases and carbapenemases
The ISME Journal · 14.01.2026 · 20 (1)
DOI: 10.1093/ismejo/wrag008 ↗Kurz gefasst
Fachartikel in der Zeitschrift The ISME Journal, online erschienen am 26.01.2026. Verfasst von Daniel Martak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), Besançon F-25000, France. Hauptthemen laut MEDLINE: beta-Lactamases, Anti-Bacterial Agents, Bacterial Proteins, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance is a serious global health threat, yet the drivers of its spread among humans are not fully understood. Antibiotics can enter the human gastrointestinal tract through the food chain, leading to the presence of low concentrations in the gut microbiota. However, the role of such traces in promoting the implantation of drug-resistant pathogens in the gut microbiota has never been explored in a controlled experimental setting. Using an in vitro model of the human gut microbiota, we tested whether traces of 19 antibiotics used in both human and veterinary medicine, alone or in combination, lead to the enrichment of Gram-negative pathogens producing extended-spectrum β-lactamases or carbapenemases. Twenty-eight strains of Gram-negative pathogens epidemic in humans (10 Escherichia coli, 6 Klebsiella pneumoniae, 5 Enterobacter hormaechei, 4 Acinetobacter baumannii, 3 Pseudomonas aeruginosa) were tested. We found that antibiotics at levels similar to those measured in the feces of healthy individuals (fluoroquinolones, 1–100 μg L−1; trimethoprim, 100 μg L−1; a mixture of fifteen veterinary antibiotics, 10–20 μg L−1) enriched the human gut microbiota with those resistant pathogens. Overall, the present study indicates that dietary consumption of some antibiotics can result in concentrations in the human colon sufficiently high to favor the implantation of exogenous antibiotic-resistant pathogens. These findings highlight the need to reassess permissible antibiotic concentrations in food and critically evaluate agricultural practices contributing to the contamination of animal- and plant-based products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Marie et Louis Pasteur, CNRS, Chrono-environnement (UMR 6249), Besançon F-25000, France.
- Hygiène Hospitalière, Centre Hospitalier Universitaire, F-25030 Besançon, France.
- Plateforme PACE, Laboratoire de Pharmacologie-Toxicologie, Centre Hospitalier Universitaire, Besançon F-25000, France.
- Agroécologie UMR1347, INRAE Centre Bourgogne-Franche-Comté, Université de Bourgogne, Dijon F-21000, France.
- Department of Biology, University of Western Ontario, London, ON N6A 5B7, Canada.
- Centre de Ressources Biologiques - Filière Microbiologique, Centre Hospitalier Universitaire, Besançon F-25030, France.
ORCID-Profile: Daniel Martak, Thibault Bourdin, Benoit Valot, Xavier Bertrand, Edward Topp, Didier Hocquet
Zitieren
APA
Martak, D., Bourdin, T., Valot, B., Laboissière, A., Lirussi, F., Bertrand, X., Topp, E., & Hocquet, D. (2026). Foodborne antibiotics enrich human gut microbiota with pathogens producing extended-spectrum β-lactamases and carbapenemases. The ISME Journal, 20(1). https://doi.org/10.1093/ismejo/wrag008
Vancouver
Martak D, Bourdin T, Valot B, Laboissière A, Lirussi F, Bertrand X, et al. Foodborne antibiotics enrich human gut microbiota with pathogens producing extended-spectrum β-lactamases and carbapenemases. The ISME Journal. 2026;20(1). doi:10.1093/ismejo/wrag008
BibTeX
@article{Martak2026,
author = {Martak, Daniel and Bourdin, Thibault and Valot, Benoit and Laboissière, Audrey and Lirussi, Frédéric and Bertrand, Xavier and Topp, Edward and Hocquet, Didier},
title = {Foodborne antibiotics enrich human gut microbiota with pathogens producing extended-spectrum β-lactamases and carbapenemases},
journal = {The ISME Journal},
year = {2026},
volume = {20},
number = {1},
doi = {10.1093/ismejo/wrag008}
}
EUVIMED